Translational research in amyotrophic lateral sclerosis (ALS)

Hae kokoteksti

Synthetic whole embryo models and their applications

Hae kokoteksti
Series

Translational medicine the risk of failure in delay and how to reduce it /

Hae kokoteksti
Series

SARS-CoV-2 monoclonal antibody testing in vivo

Hae kokoteksti
Series

mRNA COVID-19 vaccine efficacy in recovered vs COVID-naive individuals

Hae kokoteksti
Series

SARS-CoV-2 variants implications for immunity and vaccine development /

Hae kokoteksti
Series

SARS-CoV-2 evolution emergence of the "Californian" and "Indian" variants /

Hae kokoteksti
Series

SARS-COV-2 human monoclonal antibody therapy update

Hae kokoteksti
Series

Emergence of blood clotting disorders resulting from COVID vaccines inoculations

Hae kokoteksti
Series

SARS-CoV-2 evolution within and between individuals

Hae kokoteksti
Series

Identifying SARS-CoV-2 proteases

Hae kokoteksti
Series

Genetic surveillance and the emergence of SARS-CoV-2 variants

Hae kokoteksti
Series

The immune system response to the SARS-CoV-2 virus March 2021 update /

Hae kokoteksti
Series

ABO blood groups and SARS-CoV-2 susceptibility

Hae kokoteksti
Series

Comparison of COVID-19 and seasonal HCoV pathologies and transfer to endemic state

Hae kokoteksti
Series

The role of short linear motifs (SLiMs) in SARS-CoV-2 entry into human cells

Hae kokoteksti
Series

The role of Neuropilin-1 as a SARS-CoV-2-specific endocytosis potentiator

Hae kokoteksti
Series

COVID-19 epidemiology and variants new challenges and future of the pandemic /

Hae kokoteksti
Series

Interspecies transmission of SARS-CoV-2

Hae kokoteksti
Series

Complement activation in COVID-19

Hae kokoteksti
Series